Fluoxetine in Functional Constipation with Somatic Symptom Disorder: Efficacy and Safety from a Propensity Score-Matched Cohort Study
fluoxetine appears to be a safe and effective therapeutic option over a six-month period for patients with FC and SSD, exerting dual benefits in alleviating both constipation and associated psychological symptoms.
Authors
- Xu‐zhao Li (ORCID: https://orcid.org/0000-0002-1367-3445)
- Qian Huang (ORCID: https://orcid.org/0000-0002-5447-2770)
- Xue Jiang (ORCID: https://orcid.org/0000-0001-7441-0828)
- Xiangying Feng
- Zhifeng Zhao
- Weihong Fu (ORCID: https://orcid.org/0000-0002-5370-6467)
- Bin Yang (ORCID: https://orcid.org/0009-0001-6453-8120)
- Qingchuan Zhao (ORCID: https://orcid.org/0000-0003-4169-4945)
Institutions
- Medical Center Hospital (US)
- Xijing Hospital (CN)
- The Fourth People's Hospital of Ningxia Hui Autonomous Region (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Revista Española de Enfermedades Digestivas
- Published
- 2025-01-01
- DOI
- https://doi.org/10.17235/reed.2025.11434/2025
- Citations
- 1
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.81